Loading... 2 0 5 0 false
Credit Name
Abrunhosa, Antero
Full Name
Abrunhosa, Antero José Pena Afonso de
Abrunhosa, Antero J.
Main Affiliation
Ciência ID
Scopus Author ID
First degree in Biochemistry (1992) and MSc in Biomedical Engineering (1996) from the University of Coimbra, Portugal. PhD work under Prof. Terry Jones’ supervision at the MRC - Cyclotron Unit, Hammersmith Hospital in London, UK (2002). From 2000 to 2009, helped to design and supervised the construction of the Institute for Nuclear Sciences Applied to Health (ICNAS) a leading facility in Portugal for Nuclear Imaging based at the University of Coimbra. He is the current Director of the Institute and the head of the Radiochemistry Laboratory (RCL). ICNAS has extensive expertise in the development of radiopharmaceuticals for Oncology, Cardiology and Neuroscience and is fully equipped for clinical imaging (2 PET/CT and a 3T MR) as well as pre-clinical studies (including an in-house developed world leading high-resolution small animal PET with 0.3 mm resolution, a 9.4T micro-MRI, an optical imaging system and a photoacoustic tomography device). The RCL hosts 2 cyclotrons (IBA cyclone 18/9 and the first IBA Kiube variable energy, installed in 2019) and is fully licensed as a GMP manufacturing site, currently producing more than 20 different tracers based on 11C, 13N, 18F, 68Ga, 61Cu and 64Cu. The facility is the main supplier of PET radiopharmaceuticals for Portugal, through its subsidiary (ICNAS-P, a company fully owned by the University) that currently has 6 radiopharmaceuticals in the market (FDG, FCH, NaF, 68Ga-DOTANOC, 68Ga-PSMA-11 and F-DOPA). Antero is manager and Head of Production for ICNAS-P from the start. Antero’s research interests include development of targeted probes for molecular imaging, PET, SPECT, radiopharmaceutical development, PET Radiopharmacy and Quality Control, pre-clinical imaging and clinical trials. The Institute is currently participating in more than 30 clinical trials and has recently received approval, by the authorities, of its first investigator driven clinical trial. Regarding technology transfer, Antero promoted the start of 3 spin-off companies from the University of Coimbra, one of them (Fluidomica, Lda) specializes in supplying target solutions for radiometal production. He is a member of the European Pharmacopoeia Group 14 and an Expert in several Technical Committees and Field Missions for IAEA (International Atomic Energy Agency). He currently holds patents in Europe, US and Japan regarding the production of gallium-68 using liquid targets.
Loading... 3 0 5 0 false
UC Researcher


Results 1-15 of 15 (Search time: 0.039 seconds).

Issue DateTitleAuthor(s)TypeAccess
120-May-2022ADVANCED MICROWAVE TECHNOLOGY IN RADIOPHARMACEUTICAL SYNTHESISNeves, Ângela Cristina BarrôcodoctoralThesisembargoedAccess
22010Aspectos do controlo da qualidade da fluodesoxiglucose num laboratório de produçãoRodrigues, M. C. ; Clemente, G. ; Oterelo, J. P. ; Abrunhosa, A. ; Rodrigues, A. conferenceObjectopenAccess
313-Apr-2021Automatic classification of idiopathic Parkinson's disease and atypical parkinsonian syndromes combining [11C]raclopride PET uptake and MRI grey matter morphometryMartins, Ricardo Filipe Alves ; Oliveira, Francisco Paulo Marques de ; Moreira, Fradique Vieira de Almeida ; Moreira, Ana Paula ; Abrunhosa, Antero José Pena Afonso de ; Santos, Maria Cristina Januário ; Castelo-Branco, Miguel articleopenAccess
423-Jan-2021Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's DiseaseJorge, Lília; Martins, Ricardo Filipe Alves ; Canário, Nádia; Xavier, Carolina; Abrunhosa, Antero José Pena Afonso de ; Santana, Isabel ; Castelo-Branco, Miguel articleopenAccess
510-Sep-2019Labelling and validation of [61Cu]DOTA-NOC for somatostatin receptors imagingFonseca, Alexandra Isabel SimõesmasterThesisembargoedAccess
619-Jan-2021A link between synaptic plasticity and reorganization of brain activity in Parkinson's diseaseRebelo, Diliana ; Oliveira, Francisco ; Abrunhosa, Antero ; Januário, Cristina ; Lemos, João ; Castelo-Branco, Miguel articleopenAccess
72002Métodos computacionais no desenvolvimento de radiofármacos para a tomografia por emissão de positrões.Abrunhosa, Antero José Pena Afonso de doctoralThesisembargoedAccess
818-Jun-2020Novos biomarcadores morfométricos do cerebelo por ressonância magnética: validação na doença de Machado-JosephFaustino, Ricardo Jorge FerreiradoctoralThesisopenAccess
92012Optimisation of synthesis, purification and reformulation of (R)-[N-methyl-¹¹C] PK11195 for in vivo PET imaging studiesAlves, Vítor Hugo Pereira masterThesisopenAccess
1019-Jun-2019A positron-emission tomography (PET)/magnetic resonance imaging (MRI) platform to track in vivo small extracellular vesiclesBanerjee, Arnab; Alves, Vitor; Rondão, Tiago; Sereno, José; Neves, Ângela; Lino, Miguel ; Ribeiro, Andreia; Abrunhosa, Antero ; Ferreira, Lino articleembargoedAccess
11Dec-2013Radiosynthesis and in vivo evaluation of a 18F-labelled styryl-benzoxazole derivative for β-amyloid targetingMorais, G. Ribeiro ; Gano, L. ; Kniess, T. ; Bergmann, R. ; Abrunhosa, A. ; Santos, I. ; Paulo, A. articleopenAccess
122010Síntese de [18F]-FDG no módulo syntheraFernandes, E. ; Vitório, R. ; Oterelo, J. P. ; Clemente, G. ; Rodrigues, M. C. ; Guerreiro, C. ; Abrunhosa, A. ; Rodrigues, A. conferenceObjectopenAccess
1311-Jul-2014Síntese de macrociclos tetrapirrólicos fluorados. Desenvolvimento de potenciais marcadores para tomografia por emissão de positrõesSimões, Ana Vanessa Cordeiro doctoralThesisopenAccess
142010Síntese e purificação de [11C]-racloprideClemente, G. ; Oterelo, J. P. ; Rodrigues, M. C. ; Abrunhosa, A. ; Rodrigues, A. conferenceObjectopenAccess
1527-Feb-2020Synthesis Optimisation of High Specific Activity Carbon-11 Radiopharmaceuticals for Brain PET StudiesRodrigues, Iolanda Beatriz AlbuquerquemasterThesisopenAccess